* Collegium Pharmaceutical Inc COLL.OQ reported quarterly
adjusted earnings of $1.45 per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -51 cents. The mean expectation of six analysts
for the quarter was for earnings of 73 cents per share. Wall
Street expected results to range from 65 cents to 78 cents per
share.
* Revenue rose 0.1% to $144.92 million from a year ago;
analysts
expected $146.85 million.
* Collegium Pharmaceutical Inc's reported EPS for the
quarter was
71 cents.
* The company reported quarterly net income of $27.71
million.
* Collegium Pharmaceutical Inc shares had fallen by 2.0%
this
quarter and gained 23.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 12%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $40.00
This summary was machine generated from LSEG data May 9 at 09:52
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.73 1.45 Beat
Dec. 31 2023 0.66 0.82 Beat
Sep. 30 2023 0.52 0.53 Beat
Jun. 30 2023 0.29 0.34 Beat